BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33664730)

  • 1. Surface NKG2C Identifies Differentiated αβT-Cell Clones Expanded in Peripheral Blood.
    Kovalenko EI; Zvyagin IV; Streltsova MA; Mikelov AI; Erokhina SA; Telford WG; Sapozhnikov AM; Lebedev YB
    Front Immunol; 2020; 11():613882. PubMed ID: 33664730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late Development of FcεRγ
    Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
    Front Immunol; 2018; 9():1050. PubMed ID: 29868012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.
    Heath J; Newhook N; Comeau E; Gallant M; Fudge N; Grant M
    J Immunol Res; 2016; 2016():7470124. PubMed ID: 27314055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infection.
    Lopez-Vergès S; Milush JM; Schwartz BS; Pando MJ; Jarjoura J; York VA; Houchins JP; Miller S; Kang SM; Norris PJ; Nixon DF; Lanier LL
    Proc Natl Acad Sci U S A; 2011 Sep; 108(36):14725-32. PubMed ID: 21825173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
    Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
    J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia.
    Giménez E; Solano C; Amat P; de la Cámara R; Nieto J; López J; Garcia-Noblejas A; Navarro D
    J Med Virol; 2015 Sep; 87(9):1601-7. PubMed ID: 25802229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping and Characterization of HCMV-Specific Unconventional HLA-E-Restricted CD8 T Cell Populations and Associated NK and T Cell Responses Using HLA/Peptide Tetramers and Spectral Flow Cytometry.
    Rousselière A; Delbos L; Bressollette C; Berthaume M; Charreau B
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD56
    Kobyzeva PA; Streltsova MA; Erokhina SA; Kanevskiy LM; Telford WG; Sapozhnikov AM; Kovalenko EI
    J Leukoc Biol; 2020 Oct; 108(4):1379-1395. PubMed ID: 32930385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional profile of cytomegalovirus (CMV)-specific CD8+ T cells and kinetics of NKG2C+ NK cells associated with the resolution of CMV DNAemia in allogeneic stem cell transplant recipients.
    Muñoz-Cobo B; Solano C; Benet I; Costa E; Remigia MJ; de la Cámara R; Nieto J; López J; Amat P; Garcia-Noblejas A; Bravo D; Clari MÁ; Navarro D
    J Med Virol; 2012 Feb; 84(2):259-67. PubMed ID: 22170546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes.
    Costa-García M; Ataya M; Moraru M; Vilches C; López-Botet M; Muntasell A
    Front Immunol; 2019; 10():687. PubMed ID: 31001281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.
    Della Chiesa M; Falco M; Bertaina A; Muccio L; Alicata C; Frassoni F; Locatelli F; Moretta L; Moretta A
    J Immunol; 2014 Feb; 192(4):1471-9. PubMed ID: 24442432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinctive phenotype for HLA-E- versus HLA-A2-restricted memory CD8 αβT cells in the course of HCMV infection discloses features shared with NKG2C
    Rousselière A; Gérard N; Delbos L; Guérif P; Giral M; Bressollette-Bodin C; Charreau B
    Front Immunol; 2022; 13():1063690. PubMed ID: 36532017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirus.
    Martínez-Rodríguez JE; Munné-Collado J; Rasal R; Cuadrado E; Roig L; Ois A; Muntasell A; Baro T; Alameda F; Roquer J; López-Botet M
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2653-9. PubMed ID: 23968979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection.
    Holder KA; Lajoie J; Grant MD
    Front Immunol; 2018; 9():2494. PubMed ID: 30483249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts.
    Gumá M; Budt M; Sáez A; Brckalo T; Hengel H; Angulo A; López-Botet M
    Blood; 2006 May; 107(9):3624-31. PubMed ID: 16384928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C
    Comeau EM; Holder KA; Fudge NJ; Grant MD
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30857329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK cells generate memory-type responses to human cytomegalovirus-infected fibroblasts.
    Newhook N; Fudge N; Grant M
    Eur J Immunol; 2017 Jun; 47(6):1032-1039. PubMed ID: 28475279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity.
    Wu Z; Sinzger C; Frascaroli G; Reichel J; Bayer C; Wang L; Schirmbeck R; Mertens T
    J Virol; 2013 Jul; 87(13):7717-25. PubMed ID: 23637420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function.
    Foley B; Cooley S; Verneris MR; Pitt M; Curtsinger J; Luo X; Lopez-Vergès S; Lanier LL; Weisdorf D; Miller JS
    Blood; 2012 Mar; 119(11):2665-74. PubMed ID: 22180440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HCMV-controlling NKG2C
    Bozzano F; Della Chiesa M; Pelosi A; Antonini F; Ascierto ML; Del Zotto G; Moretta F; Muccio L; Luganini A; Gribaudo G; Cenderello G; Dentone C; Nicolini L; Moretta A; Moretta L; De Maria A
    J Allergy Clin Immunol; 2021 Jun; 147(6):2343-2357. PubMed ID: 33493558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.